Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines

作者：Chaojun Hu, Chenguang Niu, Xiaohui Li, Xiaohui Li, Ke He, Mengyu Li, Xiaonan Gao, Qiannan Wei, Weiyang Sun, Yongkun Zhao, Yuanguo Li, Xianzhu Xia, Zhiguang Ren, Xiaodong Li, Xiaodong Li, Tiecheng Wang · 发表于：Frontiers in Immunology · 年份：2025 · DOI：10.3389/fimmu.2025.1578733 · 被引用次数：4 · 研究领域：SARS-CoV-2 and COVID-19 Research、Influenza Virus Research Studies、Respiratory viral infections research

COVID-19 and seasonal influenza have taken a huge toll on the global economy and global health. Given the potential of COVID-19 to transform into a chronic epidemic akin to seasonal influenza, the influenza virus and SARS-CoV-2 will continue to be a significant threat to healthcare for some time to come. Coinfection involving the two viruses has been proven to worsen the severity of the illness, as evidenced by clinical observational data. Vaccination remains the most effective measure in the prevention and treatment of infectious diseases. In addition, the coadministration of influenza virus and SARS-CoV-2 vaccines offered greater benefits than either vaccine alone. Combination vaccines are also a major hotspot in novel vaccine development. This review highlights the advancements in the development of combined vaccines for COVID-19 and seasonal influenza, as demonstrated in animal studies and clinical trials, and emphasizes the importance of a combined vaccine.